U.S. court rejects Allergan bid to shield patents through tribe deal

A U.S. appeals court on Friday rejected a novel strategy adopted by drug company Allergan PLC to shield patents from review by an administrative court by transferring them to a Native American tribe.

Source: Reuters: Health - July 20, 2018 Category: Consumer Health News Tags: healthNews Source Type: news